AWM
IBB icon

Aberdeen Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Aberdeen Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8K Sell
20
-100
-83% -$17.2K ﹤0.01% 376
2026
Q1 		$20.3K Hold
120
– – 0.01% 164
2025
Q4 		$20.3K Hold
120
– – 0.01% 164
2025
Q3 		$17.3K Hold
120
– – 0.01% 154
2025
Q2 		$15.2K Hold
120
– – 0.01% 154
2025
Q1 		$15.3K Hold
120
– – 0.01% 149
2024
Q4 		$15.9K Sell
120
-17
-12% -$2.39K 0.01% 155
2024
Q3 		$19.9K Sell
137
-400
-74% -$57.9K 0.01% 158
2024
Q2 		$73.7K Buy
537
+17
+3% +$2.27K 0.05% 150
2024
Q1 		$71.4K Buy
520
+400
+333% +$54.6K 0.04% 153
2023
Q4 		$16.3K Sell
120
-400
-77% -$48.8K 0.01% 153
2023
Q3 		$63.6K Hold
520
– – 0.05% 145
2023
Q2 		$66K Hold
520
– – 0.05% 144
2023
Q1 		$67.2K Hold
520
– – 0.05% 146
2022
Q4 		$68.3K Hold
520
– – 0.05% 146
2022
Q3 		$61K Hold
520
– – 0.05% 140
2022
Q2 		$61K Hold
520
– – 0.05% 144
2022
Q1 		$68K Hold
520
– – 0.05% 149
2021
Q4 		$79K Buy
+520
New +$80.5K 0.05% 146
2021
Q2 		– Sell
-520
Closed -$78K – 133
2021
Q1 		$78K Hold
520
– – 0.06% 133
2020
Q4 		$79K Sell
520
-17
-3% -$2.43K 0.06% 139
2020
Q3 		$73K Buy
+537
New +$72.9K 0.07% 123
2020
Q2 		– Sell
-17
Closed -$2K – 131
2020
Q1 		$2K Buy
+17
New +$1.96K ﹤0.01% 119

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Aberdeen Wealth Management's IBB Position: Q2 2026 in Review

Aberdeen Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 83% in Q2 2026, selling an estimated $17.2K and leaving 20 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #376.

Aberdeen Wealth Management first reported a position in IBB in Q1 2020 and has held it in 23 quarters since. The position peaked at $79K in Q4 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Aberdeen Wealth Management held 20 shares of iShares Biotechnology ETF worth $3.8K as of Q2 2026.
  • Aberdeen Wealth Management sold 100 iShares Biotechnology ETF shares in Q2 2026, an estimated $17.2K.
  • iShares Biotechnology ETF made up ﹤0.01% of Aberdeen Wealth Management's portfolio in Q2 2026, its #376 holding.
  • Aberdeen Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2020 and has held it in 23 quarters since.
  • Aberdeen Wealth Management's iShares Biotechnology ETF position peaked at $79K in Q4 2021.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Aberdeen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.